Peter F. Pasternack
About
In The Last Decade
Peter F. Pasternack
14 papers receiving 550 citations
Peers
Comparison fields: 5 of 50
- Cardiology and Cardiovascular Medicine 488
- Surgery 364
- Pulmonary and Respiratory Medicine 252
- Radiology, Nuclear Medicine and Imaging 117
- Toxicology 79
Countries citing papers authored by Peter F. Pasternack
This map shows the geographic impact of Peter F. Pasternack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter F. Pasternack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter F. Pasternack more than expected).
Fields of papers citing papers by Peter F. Pasternack
This network shows the impact of papers produced by Peter F. Pasternack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter F. Pasternack. The network helps show where Peter F. Pasternack may publish in the future.
Co-authorship network of co-authors of Peter F. Pasternack
This figure shows the co-authorship network connecting the top 25 collaborators of Peter F. Pasternack. A scholar is included among the top collaborators of Peter F. Pasternack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter F. Pasternack. Peter F. Pasternack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 26 | |
| 2 | 6 | |
| 3 | 34 | |
| 4 | 14 | |
| 5 | Mesulergine: a dopamine agonist with novel properties in Parkinson's disease. | 1 |
| 6 | 13 | |
| 7 | 28 | |
| 8 | 108 | |
| 9 | 92 | |
| 10 | The hemodynamics of beta-blockade in patients undergoing abdominal aortic aneurysm repair. | 49 |
| 11 | The neuroleptic malignant syndrome after open heart surgery: successful treatment with bromocriptine. | 8 |
| 12 | 4 | |
| 13 | 110 | |
| 14 | 109 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.